Skip to content
PFE Pfizer Inc NYSE
43.61 USD -0.34% -0.15
OPEN 43.82
PREV CLOSE 43.76
DAY RANGE 43.90 - 43.25
VOLUME 20.1M
AVG. VOLUME 27.9M
52 WEEK RANGE 56.32 - 41.45
Interactive Brokers Logotype

Buy PFE stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 247.3B
Enterprise value 247.9B
Trailing pe 8.054845
Forward pe 10.852218
Peg ratio 10.852218
Price to sales ttm 2.4650898
Price to book mrq 2.6693323
Enterprise to revenue 2.471
Enterprise to ebitda 5.691

Financials

Fiscal year ends 2022-12-31
Most recent quarter 2022-12-31
Profit margin 0.31269
Operating margin 0.38742
Return on assets ttm 0.17287229645957
Return on equity ttm 0.36866
Income statement
Revenue ttm 100.3B
Revenue per share ttm 17.891
Quarterly revenue growth 0.028
Gross profit ttm 66.1B
Ebitda 44.7B
Net income to common ttm 31.4B
Diluted eps ttm 5.47
Quarterly earnings growth yoy 0.472
Balance sheet
Total cash mrq 36.1B
Total cash per share mrq 6.437
Total debt mrq 37B
Total debt to equity mrq 39.831
Current ratio mrq 1.9477397222376
Book value per share mrq 16.506
Cash flow
Operating cash flow ttm 32.6B
Levered free cash flow ttm 50.5B

Stock statistics

Shares outstanding 5.6B
Float shares 5.6B
Avg 10 volume 27.9M
Avg 30 volume 22.9M
Shares short 37.2M
Short ratio 1.72
Short percent of shares outstanding 0.0066000004
Percent held by insiders 0.00051
Percent held by institutions 0.70471

Stock price summary

Fifty two week low 41.45
Fifty two week high 56.32
Fifty two week change -18.551
Beta 0.633065
Day 50 ma 48.891
Day 200 ma 48.61305

Dividends and splits

Forward annual dividend rate 1.64
Forward annual dividend yield 0.0373
Trailing annual dividend rate 1.6
Trailing annual dividend yield 0.0360848
5 year average dividend yield 3.59
Payout ratio 0.2925
Dividend date 2023-03-03
Ex dividend date 2023-01-26
Last split factor 1054-for-1000 split
Last split date 2020-11-17

Pfizer Inc. (PFE) Company Profile

Pfizer is an American multinational pharmaceutical company that develops, manufactures, and sells healthcare products globally. The pharmaceutical company was founded in 1849 by Charles F. Erhart and Charles Pfizer in New York. The Company went public in June 1942, and it trades on the New York Stock Exchange (NYSE) under the ticker PFE. 

Pfizer’s product portfolio includes medicines and vaccines. The Company manages operations through two business segments:

  • Pfizer Innovative Health (IH) segment focuses on developing and commercializing medicines and vaccines globally. The IH therapeutic sector comprises internal medicine, vaccines, oncology, inflammation and immunology, rare diseases, and consumer healthcare.
  • Pfizer Essential Health (EH) segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars, and infusion systems. Furthermore, EH also consists of a research and development (R&D) organization and its contract manufacturing business.

Common Pfizer brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq, and Viagra. 

Pfizer’s main competitors 

  • Merck & Co.
  • Novartis AG
  • Eli Lilly & Co
  • Bristol Myers Squibb
  • Johnson & Johnson

Key Pfizer milestones 

In December 2020, Pfizer’s coronavirus vaccine was the first to be approved in the United Kingdom. This is after the company reported an over 95% success rate. 

In 2000, Pfizer acquired Warner-Lambert for $111.8 billion. The deal at the time created the second-largest pharmaceutical company in the world. Warner-Lambert was a Philadelphia drug company known for inventing a tablet-coating.

In 2018, Pfizer signed a deal with the German biotechnology company BioNTech, to conduct joint research and development activities. Under the agreement, Pfizer would assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines. The collaborative partnership was credited with the development of the coronavirus vaccine. 

Between 2010 and 2011, Pfizer recorded one of its biggest revenues in history at $65.16 billion and $65.25 billion, respectively. 

Pfizer Frequently Asked Questions

How often does Pfizer pay dividends?

Pfizer pays dividends four times per year, excluding specials. Typically, dividends cover is approximately 2.0.

Has Pfizer split its stock?

In the company’s history, Pfizer has split its stock six times. The 6th split took place on November 17, 2020.

Why is Pfizer successful?

Pfizer’s success is based on continuous research and development as well as long-term planning. Pfizer constantly offers effective medicines in the fight against and prevention of diseases.

AD